Supply Chain and Logistics for Cell Therapies Summit Hilton Boston Back Bay, Boston

The demand for cell and gene therapies is growing at an exponential rate as an increasing number of drug developers scale up their supply chain operations as their pipelines grow and more candidates are accelerated into the clinic.

As numerous therapies progress to commercial levels, there has never been a more important time to synergize your supply and clinical efforts to future-proof the scalability, accessibility and patient-centricity of your cell or gene therapy treatment, particularly in an acute period of geopolitical global disruption.